Stocks and Investing Stocks and Investing
Tue, July 7, 2020
Mon, July 6, 2020
Sun, July 5, 2020
Thu, July 2, 2020
Wed, July 1, 2020
Tue, June 30, 2020
Mon, June 29, 2020

Vamil Divan Maintained (ABBV) at Strong Buy with Increased Target to $110 on, Jun 29th, 2020


Published on 2024-10-27 08:50:16 - WOPRAI, Vamil Divan
  Print publication without navigation


Vamil Divan of Mizuho, Maintained "AbbVie Inc." (ABBV) at Strong Buy with Increased Target from $101 to $110 on, Jun 29th, 2020.

Vamil has made no other calls on ABBV in the last 4 months.



There are 8 other peers that have a rating on ABBV. Out of the 8 peers that are also analyzing ABBV, 2 agree with Vamil's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jason Gerberry of "B of A Securities" Initiated at Hold and Held Target at $95 on, Monday, May 18th, 2020
  • Justin Smith of "Societe Generale" Downgraded from Strong Buy to Hold on, Monday, March 23rd, 2020


These are the ratings of the 6 analyists that currently disagree with Vamil


  • Randall Stanicky of "RBC Capital" Maintained at Buy with Increased Target to $125 on, Thursday, June 25th, 2020
  • Steve Chesney of "Atlantic Equities" Upgraded from Hold to Buy and Held Target at $115 on, Tuesday, June 23rd, 2020
  • Navin Jacob of "UBS" Maintained at Strong Buy with Increased Target to $109 on, Wednesday, June 17th, 2020
  • David Toung of "Argus Research" Upgraded from Hold to Strong Buy and Held Target at $115 on, Tuesday, June 2nd, 2020
  • Geoffrey Porges of "SVB Leerink" Maintained at Buy with Increased Target to $122 on, Monday, May 11th, 2020
  • David Risinger of "Morgan Stanley" Initiated at Buy and Held Target at $95 on, Monday, May 11th, 2020